Liposidomycins: novel nucleoside antibiotics which inhibit bacterial peptidoglycan synthesis.
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents / Q000302:isolation & purification* / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects* / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D009705:Nucleosides / Q000302:isolation & purification / Q000494:pharmacology; D010457:Peptidoglycan / Q000096:biosynthesis*; D013302:Streptomyces / Q000378:metabolism*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D009705:Nucleosides; D010457:Peptidoglycan; C047544:liposidomycins